These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 462170)

  • 1. [Dissociation of human factor VIII and recombination of the fragments VIII-C and VIII-AG].
    Tran TH; Bounameaux H; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1979 Jul; 109(28):1029-34. PubMed ID: 462170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA; Andersen JC; Pizzo SV; McKee PA
    J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma.
    Muntean W
    Wien Klin Wochenschr; 1984 Nov; 96(22):829-32. PubMed ID: 6442046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
    Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H
    Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
    Muntean W; Rothwangl HJ
    Eur J Clin Invest; 1984 Dec; 14(6):462-8. PubMed ID: 6441724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding to phospholipid protects factor VIII from inactivation by human antibodies.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    J Lab Clin Med; 1983 Jan; 101(1):34-43. PubMed ID: 6401316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
    Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
    Ann Clin Lab Sci; 1986; 16(6):497-501. PubMed ID: 3099625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.
    Over J; Bouma BN; van Mourik JA; Sixma JJ; Vlooswijk R; Bakker-Woudenberg I
    J Lab Clin Med; 1978 Jan; 91(1):32-46. PubMed ID: 618989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stability of factor VIII in heparinized plasma.
    Krachmalnicoff A; Thomas DP
    Thromb Haemost; 1983 Jun; 49(3):224-7. PubMed ID: 6410534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T; Koller E; Doleschel W
    Thromb Haemost; 1979 Oct; 42(3):832-7. PubMed ID: 505400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL; Morrissey JH; Neuenschwander PF
    Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE; Thuy LP; Carton CL; Hougie C
    J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin.
    Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
    Ann Clin Lab Sci; 1985; 15(6):482-7. PubMed ID: 3933404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting.
    Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Sawamoto Y; Kamisue S; Fukui H
    Int J Hematol; 1991 Dec; 54(6):523-30. PubMed ID: 1724392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.